S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Delcath Systems Stock Forecast, Price & News

+0.64 (+3.71 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $17.91
50-Day Range
MA: $18.82
52-Week Range
Now: $17.91
Volume122,859 shs
Average Volume122,797 shs
Market Capitalization$73.74 million
P/E RatioN/A
Dividend YieldN/A
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company's lead product candidate is the melphalan hydrochloride for injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. Its Phase III clinical trial products include FOCUS Trial for the patients with hepatic dominant ocular melanoma; and ALIGN Trial for intrahepatic cholangiocarcinoma. The company also offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.
Delcath Systems logo


DCTH.N - Delcath Systems Inc Profile | Reuters
December 14, 2020 |  reuters.com
Delcath Systems stock plunges premarket after Q3 earnings
November 11, 2020 |  seekingalpha.com
Delcath Systems EPS beats by $0.47, misses on revenue
November 11, 2020 |  seekingalpha.com
Delcath Systems, Inc. Announces Third Quarter 2020 Results
November 11, 2020 |  finance.yahoo.com
LD Micro 360 Companies Set to Present this Week.
September 2, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:DCTH
Phone212 489 2100
Year FoundedN/A



Sales & Book Value

Annual Sales$1.58 million
Book Value($94.88) per share


Net Income$-8,880,000.00
Net Margins-302.74%


Market Cap$73.74 million
Next Earnings Date3/24/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.58 out of 5 stars

Medical Sector

380th out of 1,969 stocks

Surgical & Medical Instruments Industry

34th out of 169 stocks

Analyst Opinion: 2.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
+0.64 (+3.71 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DCTH News and Ratings via Email

Sign-up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Delcath Systems (NASDAQ:DCTH) Frequently Asked Questions

Is Delcath Systems a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Delcath Systems stock.
View analyst ratings for Delcath Systems
or view top-rated stocks.

What stocks does MarketBeat like better than Delcath Systems?

Wall Street analysts have given Delcath Systems a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Delcath Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Delcath Systems' next earnings date?

Delcath Systems is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Delcath Systems

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (NASDAQ:DCTH) issued its quarterly earnings results on Wednesday, November, 11th. The company reported ($1.16) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($1.63) by $0.47. The firm had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.40 million.
View Delcath Systems' earnings history

How has Delcath Systems' stock price been impacted by COVID-19?

Delcath Systems' stock was trading at $9.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DCTH shares have increased by 94.7% and is now trading at $17.91.
View which stocks have been most impacted by COVID-19

When did Delcath Systems' stock split? How did Delcath Systems' stock split work?

Shares of Delcath Systems reverse split on the morning of Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 1 shares after the split.

What price target have analysts set for DCTH?

3 brokerages have issued 12-month target prices for Delcath Systems' stock. Their forecasts range from $19.00 to $23.00. On average, they anticipate Delcath Systems' stock price to reach $20.67 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price.
View analysts' price targets for Delcath Systems
or view top-rated stocks among Wall Street analysts.

Who are Delcath Systems' key executives?

Delcath Systems' management team includes the following people:
  • Mr. John Purpura M.S., Chief Operating Officer (Age 60, Pay $623.15k)
  • Mr. Gerard J. Michel, CEO & Director (Age 58)
  • Ms. Christine Padula, Interim Principal Accounting Officer (Age 56)
  • Mr. Thomas Johnson, Sr. Director of Corp. Communications
  • Mr. Robin Wagge, Sr. VP of Rubenstein Associates

Who are some of Delcath Systems' key competitors?

What is Delcath Systems' stock symbol?

Delcath Systems trades on the NASDAQ under the ticker symbol "DCTH."

Who are Delcath Systems' major shareholders?

Delcath Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include Silverarc Capital Management LLC (8.54%), Ikarian Capital LLC (2.74%), Renaissance Technologies LLC (2.46%), AWM Investment Company Inc. (2.11%), Pura Vida Investments LLC (1.58%) and Alyeska Investment Group L.P. (1.20%). Company insiders that own Delcath Systems stock include Gerard J Michel, Gil Aharon and Steven A J Salamon.
View institutional ownership trends for Delcath Systems

Which institutional investors are selling Delcath Systems stock?

DCTH stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC.
View insider buying and selling activity for Delcath Systems
or view top insider-selling stocks.

Which institutional investors are buying Delcath Systems stock?

DCTH stock was purchased by a variety of institutional investors in the last quarter, including Silverarc Capital Management LLC, Renaissance Technologies LLC, AWM Investment Company Inc., Pura Vida Investments LLC, Alyeska Investment Group L.P., Alyeska Investment Group L.P., Verition Fund Management LLC, and Ikarian Capital LLC. Company insiders that have bought Delcath Systems stock in the last two years include Gerard J Michel, Gil Aharon, and Steven A J Salamon.
View insider buying and selling activity for Delcath Systems
or or view top insider-buying stocks.

How do I buy shares of Delcath Systems?

Shares of DCTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Delcath Systems' stock price today?

One share of DCTH stock can currently be purchased for approximately $17.91.

How much money does Delcath Systems make?

Delcath Systems has a market capitalization of $73.74 million and generates $1.58 million in revenue each year. The company earns $-8,880,000.00 in net income (profit) each year or ($1,047.00) on an earnings per share basis.

How many employees does Delcath Systems have?

Delcath Systems employs 33 workers across the globe.

What is Delcath Systems' official website?

The official website for Delcath Systems is delcath.com.

Where are Delcath Systems' headquarters?

Delcath Systems is headquartered at 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019.

How can I contact Delcath Systems?

Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The company can be reached via phone at 212 489 2100 or via email at [email protected]

This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.